Literature DB >> 8586701

Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR.

J Lan1, I Melgers, C J Meijer, J M Walboomers, R Roosendaal, C Burger, O P Bleker, A J van den Brule.   

Abstract

The prevalence rates and serovar distributions of Chlamydia trachomatis cervical infections were investigated in two different groups of women. Group I consisted of 393 asymptomatic young women (aged 17 to 30 years) who were invited to participate in a C. trachomatis screening program. Group II consisted of 734 randomly selected patients (aged 17 to 68 years) attending an inner-city gynecological outpatient clinic. C. trachomatis was detected in cervical scrapes by PCR specific for endogenous plasmid. These plasmid PCR-positive samples were subsequently subjected to genotyping by C. trachomatis-specific omp1 PCR-based restriction fragment length polymorphism analysis (J. Lan, J. M. M. Walboomers, R. Roosendaal, G. J. van Doornum, D. M. MacLaren, C. J. L. M. Meijer, and A. J. C. van den Brule, J. Clin. Microbiol. 31:1060-1065, 1993). The overall prevalence rates of C. trachomatis found in patients younger than 30 years were 9.2 and 11.8% in groups I and II, respectively. A clear age dependency was seen in group II, with the highest prevalence rate (20%) found in patients younger than 20 years, while the rate declined significantly after 30 years of age (5.9%). In women younger than 30 years, the genotyping results showed that serovars E, I, and D (in decreasing order) were frequent in group I, while serovars F, E, and G (in decreasing order) were predominantly found in group II. The study shows that C. trachomatis infections are highly prevalent in asymptomatic young women. The different serovar distributions found most likely reflect the different compositions of the study groups, but additional analysis of the case histories of individual patients suggests that certain serovars might be associated with symptomatic (i.e., serovar G) or asymptomatic (i.e., serovars D and I) infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586701      PMCID: PMC228672          DOI: 10.1128/jcm.33.12.3194-3197.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update.

Authors:  W Cates; R T Rolfs; S O Aral
Journal:  Epidemiol Rev       Date:  1990       Impact factor: 6.222

2.  Prevalence of Chlamydia trachomatis infection in a population of asymptomatic women in a screening program for cervical cancer.

Authors:  C J Meijer; J J Calame; E J de Windt; E K Risse; O P Bleker; P Kenemans; W G Quint; M J Meddens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

3.  Typing Chlamydia trachomatis by detection of restriction fragment length polymorphism in the gene encoding the major outer membrane protein.

Authors:  E H Frost; S Deslandes; S Veilleux; D Bourgaux-Ramoisy
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

4.  Chlamydiazyme plus blocking assay to detect Chlamydia trachomatis in endocervical specimens.

Authors:  R D Mills; A Young; K Cain; T M Blair; M A Sitorius; G L Woods
Journal:  Am J Clin Pathol       Date:  1992-02       Impact factor: 2.493

5.  Screening for Chlamydia trachomatis infection in women and aspects of the laboratory diagnostics.

Authors:  L O Svensson; I Mares; S E Olsson; M L Nordström
Journal:  Acta Obstet Gynecol Scand       Date:  1991       Impact factor: 3.636

6.  Detection of Chlamydia trachomatis endocervical infection in asymptomatic and symptomatic women: comparison of deoxyribonucleic acid probe test with tissue culture.

Authors:  L I Yang; E S Panke; P A Leist; R J Fry; R F Lee
Journal:  Am J Obstet Gynecol       Date:  1991-11       Impact factor: 8.661

7.  Evaluation of urogenital Chlamydia trachomatis infections by cell culture and the polymerase chain reaction using a closed system.

Authors:  L Ostergaard; J Traulsen; S Birkelund; G Christiansen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

8.  Rapid genotyping of the Chlamydia trachomatis major outer membrane protein by the polymerase chain reaction.

Authors:  C Sayada; E Denamur; J Orfila; F Catalan; J Elion
Journal:  FEMS Microbiol Lett       Date:  1991-09-15       Impact factor: 2.742

9.  Correlation of infecting serovar and local inflammation in genital chlamydial infections.

Authors:  B E Batteiger; W Lennington; W J Newhall; B P Katz; H T Morrison; R B Jones
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

10.  A prospective study of genital infections in a family-planning clinic. 2. Chlamydia infection--the identification of a high-risk group.

Authors:  M E Macaulay; T Riordan; J M James; P A Leventhall; E M Morris; B R Neal; D A Ellis
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

View more
  17 in total

1.  Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?

Authors:  S A Morré; L Rozendaal; I G van Valkengoed; A J Boeke; P C van Voorst Vader; J Schirm; S de Blok; J A van Den Hoek; G J van Doornum; C J Meijer; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States.

Authors:  Kim Millman; Carolyn M Black; Robert E Johnson; Walter E Stamm; Robert B Jones; Edward W Hook; David H Martin; Gail Bolan; Simon Tavaré; Deborah Dean
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

Review 3.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

4.  Genotyping of Portuguese Chlamydia trachomatis urogenital isolates.

Authors:  M J Borrego; J P Gomes; J F Lefebvre; F Eb; J Orfila; M A Catry
Journal:  Genitourin Med       Date:  1997-12

Review 5.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

6.  Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa.

Authors:  K Sturm-Ramirez; H Brumblay; K Diop; A Guèye-Ndiaye; J L Sankalé; I Thior; I N'Doye; C C Hsieh; S Mboup; P J Kanki
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia.

Authors:  M Molano; E Weiderpass; H Posso; S A Morré; M Ronderos; S Franceschi; A Arslan; C J L M Meijer; N Muñoz; A J C van den Brule
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

8.  The Chromosome-Encoded Hypothetical Protein TC0668 Is an Upper Genital Tract Pathogenicity Factor of Chlamydia muridarum.

Authors:  Turner Allen Conrad; Siqi Gong; Zhangsheng Yang; Patrick Matulich; Jonathon Keck; Noah Beltrami; Chaoqun Chen; Zhou Zhou; Jin Dai; Guangming Zhong
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

9.  Repeated Chlamydia trachomatis genital infections in adolescent women.

Authors:  Byron E Batteiger; Wanzhu Tu; Susan Ofner; Barbara Van Der Pol; Diane R Stothard; Donald P Orr; Barry P Katz; J Dennis Fortenberry
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

10.  Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Authors:  Jennifer R Carmichael; Delia Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  Microbes Infect       Date:  2012-12-31       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.